poisar

Stocks · News reference

Sarepta Therapeutics Q2 Adj. EPS $0.64 Beats $0.26 Estimate, Sales $401.300M Beat $364.343M Estimate

Aug 5, 2026, 8:14 PMBenzinga Newsdesk

Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly earnings of $0.64 per share which beat the analyst consensus estimate of $0.26 by 146.15 percent. This is a 68.32 percent decrease over earnings of $2.02 per share

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

SRPT
Source
benzinga
Observed
Aug 5, 2026, 8:14 PM
Checked
Aug 5, 2026, 8:14 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Jul 27, 2026, 1:08 PMSEC EDGAR

    8-K filing — Sarepta Therapeutics, Inc. (SRPT)

    Filed: 2026-07-27 AccNo: 0001193125-26-316995 Size: 334 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

    Read original at edgar
    SRPT